BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Children's Medical Group Offers Lexicor Medical Technologies, Inc.'s NeuroLex(SM) ADHD Assessment Service


3/6/2006 11:34:40 AM

AUGUSTA, Ga., March 6 /PRNewswire/ -- A new service used to aid medical professionals in their assessment of ADHD is now available at CHILDREN'S MEDICAL GROUP by Tracy Middlebrooks, M.D. and Warren Umansky, Ph.D. The NeuroLex Indicator Report Service(SM) quantitatively and objectively analyzes electroencephalogram (qEEG) data and empowers the judgment of the physician while providing comfort and assurance of objectivity for the patient. The procedure takes approximately 45 minutes. The data is then transmitted and analyzed and an indicator report is provided to the physician.

ADHD is a disorder of the brain associated with lack of impulse control, inattention and other behavior problems. It affects an estimated 7 to 10 percent of all school-age children, and an estimated 4 percent of all adults.

"Lexicor believes the NeuroLex Indicator Report Service(SM) will change the way health care professionals evaluate patients for ADHD, and in the future, other mental health conditions," said Roger Smith, President and Chief Executive Officer at Lexicor. "NeuroLex(SM) is a convergence of technologies and clinical research that increases the power of a health care professional's judgment and offers the assurance of objective data in assessment of ADHD. Children's Medical Group is providing a great service to the residents and physicians in the Augusta area and surrounding communities by offering this cutting-edge assessment technology."

NeuroLex(SM) is not a substitute for, but rather complements, the patient's history and medical examination. Neurolex(SM) is a reporting service based on medical information technology for objective, reliable analysis of EEG data to support the assessment of patients presenting with attention problems. In addition, the service is covered by many insurance providers.

About Children's Medical Group

Dr. Tracy W. Middlebrooks is a board certified pediatrician. He has been in practice since 1983. Dr. Warren Umansky is a Child Development Specialist and school counselor who has been in practice in Augusta since 1989. Children's Medical Group is a general pediatric practice in Augusta. To arrange for an interview, please call Dr. Umansky at 706-399-6200.

About Lexicor

For more than 15 years, Lexicor has been the leader in the field of digital EEG data collection, management and analysis. Lexicor is the first company to offer global access to a proprietary neuro-assessment reporting service - the NeuroLex Indicator Report Service(SM). For more information, contact Lexicor at 888-LEXICOR or visit www.lexicor.com.

Contact: Howard Merry

(706) 736-5864 hmerry@lexicor.net

Lexicor

CONTACT: Howard Merry of Lexicor, +1-706-736-5864, or hmerry@lexicor.net



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES